Mitotic and neurogenic effects of dehydroepiandrosterone (DHEA) on human neural stem cell cultures derived from the fetal cortex.

PubWeight™: 1.10‹?› | Rank: Top 10%

🔗 View Article (PMC 365767)

Published in Proc Natl Acad Sci U S A on February 18, 2004

Authors

Masatoshi Suzuki1, Lynda S Wright, Padma Marwah, Henry A Lardy, Clive N Svendsen

Author Affiliations

1: Department of Anatomy and the Waisman Center, University of Wisconsin, 1500 Highland Avenue, Madison, WI 53705-2280, USA.

Articles citing this

The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr Rev (2010) 4.95

Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS). Front Neuroendocrinol (2008) 1.87

Altered lipid metabolism in brain injury and disorders. Subcell Biochem (2008) 1.69

The corticoid environment: a determining factor for neural progenitors' survival in the adult hippocampus. Eur J Neurosci (2004) 1.18

Neurosteroid regulation of central nervous system development. Pharmacol Ther (2007) 1.12

Endogenous and synthetic neurosteroids in treatment of Niemann-Pick Type C disease. Brain Res Rev (2007) 1.05

Important precautions when deriving patient-specific neural elements from pluripotent cells. Cytotherapy (2009) 0.97

Evo-devo of human adolescence: beyond disease models of early puberty. BMC Med (2013) 0.96

Interactive effects of dehydroepiandrosterone and testosterone on cortical thickness during early brain development. J Neurosci (2013) 0.95

Dehydroepiandrosterone and age-related cognitive decline. Age (Dordr) (2009) 0.93

Activities of 3beta-HSD and aromatase in slices of developing and adult zebra finch brain. Gen Comp Endocrinol (2006) 0.88

Allopregnanolone levels are reduced in temporal cortex in patients with Alzheimer's disease compared to cognitively intact control subjects. Biochim Biophys Acta (2010) 0.87

A review of age-related dehydroepiandrosterone decline and its association with well-known geriatric syndromes: is treatment beneficial? Rejuvenation Res (2013) 0.85

Cerebrospinal fluid dehydroepiandrosterone levels are correlated with brain dehydroepiandrosterone levels, elevated in Alzheimer's disease, and related to neuropathological disease stage. J Clin Endocrinol Metab (2008) 0.83

Neural Stem Cells (NSCs) and Proteomics. Mol Cell Proteomics (2015) 0.82

Gonadectomy and dehydroepiandrosterone (DHEA) do not modulate disease progression in the G93A mutant SOD1 rat model of amyotrophic lateral sclerosis. Amyotroph Lateral Scler (2012) 0.81

In vivo tracking of human neural progenitor cells in the rat brain using bioluminescence imaging. J Neurosci Methods (2014) 0.81

Effect of dehydroepiandrosterone administration on recovery from mix-type exercise training-induced muscle damage. Eur J Appl Physiol (2012) 0.81

In Vivo Tracking of Human Neural Progenitor Cells in the Rat Brain Using Magnetic Resonance Imaging Is Not Enhanced by Ferritin Expression. Cell Transplant (2015) 0.79

Male-specific differences in proliferation, neurogenesis, and sensitivity to oxidative stress in neural progenitor cells derived from a rat model of ALS. PLoS One (2012) 0.79

Administration of dehydroepiandrosterone (DHEA) increases serum levels of androgens and estrogens but does not enhance short-term memory in post-menopausal women. Brain Res (2012) 0.79

Dehydroepiandrosterone stimulates nerve growth factor and brain derived neurotrophic factor in cortical neurons. Adv Pharmacol Sci (2013) 0.78

Roles of sigma-1 receptors in Alzheimer's disease. Int J Clin Exp Med (2015) 0.78

Constraining the Pluripotent Fate of Human Embryonic Stem Cells for Tissue Engineering and Cell Therapy - The Turning Point of Cell-Based Regenerative Medicine. Br Biotechnol J (2013) 0.77

Oxidative Stress-Mediated Brain Dehydroepiandrosterone (DHEA) Formation in Alzheimer's Disease Diagnosis. Front Endocrinol (Lausanne) (2011) 0.76

Dehydroepiandrosterone inhibits cell proliferation and improves viability by regulating S phase and mitochondrial permeability in primary rat Leydig cells. Mol Med Rep (2016) 0.75

Expression of P450c17 in the human fetal nervous system. Endocrinology (2012) 0.75

Polymorphisms of STS gene and SULT2A1 gene and neurosteroid levels in Han Chinese boys with attention-deficit/hyperactivity disorder: an exploratory investigation. Sci Rep (2017) 0.75

Articles cited by this

Neurogenesis in the adult human hippocampus. Nat Med (1998) 17.53

Mammalian neural stem cells. Science (2000) 16.09

Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell (1999) 15.87

CNS stem cells express a new class of intermediate filament protein. Cell (1990) 11.96

Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron (1994) 11.44

Stem cells in the central nervous system. Science (1997) 4.77

A multipotent EGF-responsive striatal embryonic progenitor cell produces neurons and astrocytes. J Neurosci (1992) 4.60

Regulation of gliogenesis in the central nervous system by the JAK-STAT signaling pathway. Science (1997) 4.26

A new method for the rapid and long term growth of human neural precursor cells. J Neurosci Methods (1998) 3.35

Identification of a multipotent astrocytic stem cell in the immature and adult mouse brain. Proc Natl Acad Sci U S A (2000) 2.92

The predominant neural stem cell isolated from postnatal and adult forebrain but not early embryonic forebrain expresses GFAP. J Neurosci (2003) 2.44

Pregnenolone sulfate: a positive allosteric modulator at the N-methyl-D-aspartate receptor. Mol Pharmacol (1991) 2.02

Architecture and cell types of the adult subventricular zone: in search of the stem cells. J Neurobiol (1998) 1.90

Neurosteroids: of the nervous system, by the nervous system, for the nervous system. Recent Prog Horm Res (1997) 1.80

Characterization and measurement of dehydroepiandrosterone sulfate in rat brain. Proc Natl Acad Sci U S A (1981) 1.78

Developmental requirement of gp130 signaling in neuronal survival and astrocyte differentiation. J Neurosci (1999) 1.71

Growth factors regulate the survival and fate of cells derived from human neurospheres. Nat Biotechnol (2001) 1.70

Long-term longitudinal measurements of plasma dehydroepiandrosterone sulfate in normal men. J Clin Endocrinol Metab (1992) 1.68

Neurosteroids: a novel function of the brain. Psychoneuroendocrinology (1998) 1.67

Dehydroepiandrosterone treatment of midlife dysthymia. Biol Psychiatry (1999) 1.57

The neurosteroid dehydroepiandrosterone sulfate is an allosteric antagonist of the GABAA receptor. Brain Res (1990) 1.48

Neurosteroids, via sigma receptors, modulate the [3H]norepinephrine release evoked by N-methyl-D-aspartate in the rat hippocampus. Proc Natl Acad Sci U S A (1995) 1.43

Fibroblast growth factor 2 (FGF-2) promotes acquisition of epidermal growth factor (EGF) responsiveness in mouse striatal precursor cells: identification of neural precursors responding to both EGF and FGF-2. J Neurosci (1998) 1.43

Dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEAS) protect hippocampal neurons against excitatory amino acid-induced neurotoxicity. Proc Natl Acad Sci U S A (1998) 1.42

Regional specification of rodent and human neurospheres. Brain Res Dev Brain Res (2002) 1.34

Gene expression in human neural stem cells: effects of leukemia inhibitory factor. J Neurochem (2003) 1.34

Dehydroepiandrosterone (DHEA) stimulates neurogenesis in the hippocampus of the rat, promotes survival of newly formed neurons and prevents corticosterone-induced suppression. Eur J Neurosci (2002) 1.33

Dehydroepiandrosterone: a potential signalling molecule for neocortical organization during development. Proc Natl Acad Sci U S A (1998) 1.29

Leukemia-inhibitory factor-neuroimmune modulator of endocrine function. Endocr Rev (2000) 1.28

Neural stem cell lineages are regionally specified, but not committed, within distinct compartments of the developing brain. Development (2002) 1.23

Expression of neural markers in human umbilical cord blood. Exp Neurol (2001) 1.18

Dehydroepiandrosterone (DHEA) protects hippocampal cells from oxidative stress-induced damage. Brain Res Mol Brain Res (1999) 1.13

Expression pattern of sigma receptor 1 mRNA and protein in mammalian retina. Brain Res Mol Brain Res (2001) 1.13

Receptor binding and electrophysiological effects of dehydroepiandrosterone sulfate, an antagonist of the GABAA receptor. Neuroscience (1991) 1.04

Dehydroepiandrosterone - is the fountain of youth drying out? Physiol Res (2003) 1.00

Neuroactive neurosteroids as endogenous effectors for the sigma1 (sigma1) receptor: pharmacological evidence and therapeutic opportunities. Jpn J Pharmacol (1999) 1.00

In vitro propagation and inducible differentiation of multipotential progenitor cells from human fetal brain. Neuroscience (1997) 0.98

Expression of N-methyl-D-aspartate (NMDA) and non-NMDA glutamate receptor genes in neuroblastoma, medulloblastoma, and other cells lines. J Neurosci Res (1996) 0.93

In vitro metabolism of dehydroepiandrosterone (DHEA) to 7alpha-hydroxy-DHEA and Delta5-androstene-3beta,17beta-diol in specific regions of the aging brain from Alzheimer's and non-demented patients. Brain Res (2003) 0.90

Generation of regionally specified neurons in expanded glial cultures derived from the mouse and human lateral ganglionic eminence. Mol Cell Neurosci (2001) 0.90

Ergosteroids. II: Biologically active metabolites and synthetic derivatives of dehydroepiandrosterone. Steroids (1998) 0.84

The effect of 7-oxo-DHEA acetate on memory in young and old C57BL/6 mice. Steroids (2000) 0.84

Restricted growth potential of rat neural precursors as compared to mouse. Brain Res Dev Brain Res (1997) 0.84

Transformations of DHEA and its metabolites by rat liver. Lipids (2002) 0.79

Review: Ageing and hormones. Eur J Clin Invest (1999) 0.77

Ergosteroids IV: synthesis and biological activity of steroid glucuronosides, ethers, and alkylcarbonates. Steroids (2001) 0.76

Articles by these authors

Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature (2008) 12.21

Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat Med (2003) 4.51

Modeling early retinal development with human embryonic and induced pluripotent stem cells. Proc Natl Acad Sci U S A (2009) 3.53

Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion. Sci Transl Med (2013) 2.89

Neuronal target genes of the neuron-restrictive silencer factor in neurospheres derived from fetuses with Down's syndrome: a gene expression study. Lancet (2002) 2.29

Human neural stem cells enhance structural plasticity and axonal transport in the ischaemic brain. Brain (2011) 2.27

Optic vesicle-like structures derived from human pluripotent stem cells facilitate a customized approach to retinal disease treatment. Stem Cells (2011) 2.26

Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS. Mol Ther (2008) 2.14

GDNF secreting human neural progenitor cells protect dying motor neurons, but not their projection to muscle, in a rat model of familial ALS. PLoS One (2007) 1.99

Intraputamenal infusion of glial cell line-derived neurotrophic factor in PD: a two-year outcome study. Ann Neurol (2005) 1.86

GDNF delivery using human neural progenitor cells in a rat model of ALS. Hum Gene Ther (2005) 1.72

iPS cell modeling of Best disease: insights into the pathophysiology of an inherited macular degeneration. Hum Mol Genet (2012) 1.59

Blood-brain barrier modeling with co-cultured neural progenitor cell-derived astrocytes and neurons. J Neurochem (2011) 1.51

Blood-derived human iPS cells generate optic vesicle-like structures with the capacity to form retinal laminae and develop synapses. Invest Ophthalmol Vis Sci (2012) 1.50

Inhibition of apoptosis blocks human motor neuron cell death in a stem cell model of spinal muscular atrophy. PLoS One (2012) 1.40

Combining growth factor and stem cell therapy for amyotrophic lateral sclerosis. Trends Neurosci (2008) 1.38

Protection of visual functions by human neural progenitors in a rat model of retinal disease. PLoS One (2007) 1.38

Human neural progenitor cells over-expressing IGF-1 protect dopamine neurons and restore function in a rat model of Parkinson's disease. Exp Neurol (2007) 1.36

Human neural stem cell transplants improve motor function in a rat model of Huntington's disease. J Comp Neurol (2004) 1.35

Gene expression in human neural stem cells: effects of leukemia inhibitory factor. J Neurochem (2003) 1.34

Human progenitor cells isolated from the developing cortex undergo decreased neurogenesis and eventual senescence following expansion in vitro. Exp Cell Res (2006) 1.33

Gene therapy-mediated delivery of targeted cytotoxins for glioma therapeutics. Proc Natl Acad Sci U S A (2010) 1.29

Differentiating embryonic neural progenitor cells induce blood-brain barrier properties. J Neurochem (2007) 1.29

Induced pluripotent stem cells: a new revolution for clinical neurology? Lancet Neurol (2011) 1.26

Human stem cells and drug screening: opportunities and challenges. Nat Rev Drug Discov (2010) 1.24

Long-term vision rescue by human neural progenitors in a rat model of photoreceptor degeneration. Invest Ophthalmol Vis Sci (2008) 1.22

A novel serum-free method for culturing human prenatal retinal pigment epithelial cells. Invest Ophthalmol Vis Sci (2008) 1.21

Using human neural stem cells to model neurological disease. Nat Rev Genet (2004) 1.20

Intermittent hypoxia and stem cell implants preserve breathing capacity in a rodent model of amyotrophic lateral sclerosis. Am J Respir Crit Care Med (2012) 1.20

GDNF-secreting human neural progenitor cells increase tyrosine hydroxylase and VMAT2 expression in MPTP-treated cynomolgus monkeys. Cell Transplant (2008) 1.19

Crossroads in GDNF therapy for Parkinson's disease. Mov Disord (2006) 1.19

Sexual dimorphism in disease onset and progression of a rat model of ALS. Amyotroph Lateral Scler (2007) 1.13

Over-expression of alpha-synuclein in human neural progenitors leads to specific changes in fate and differentiation. Hum Mol Genet (2007) 1.13

Chromosome 7 and 19 trisomy in cultured human neural progenitor cells. PLoS One (2009) 1.13

FGF-dependent generation of oligodendrocytes by a hedgehog-independent pathway. Development (2003) 1.11

Lentiviral vector-mediated genetic modification of human neural progenitor cells for ex vivo gene therapy. J Neurosci Methods (2007) 1.11

Human induced pluripotent stem cells are a novel source of neural progenitor cells (iNPCs) that migrate and integrate in the rodent spinal cord. J Comp Neurol (2014) 1.09

Glutamate enhances proliferation and neurogenesis in human neural progenitor cell cultures derived from the fetal cortex. Eur J Neurosci (2006) 1.07

Functional analysis of serially expanded human iPS cell-derived RPE cultures. Invest Ophthalmol Vis Sci (2013) 1.07

Synergistic effects of GDNF and VEGF on lifespan and disease progression in a familial ALS rat model. Mol Ther (2013) 1.06

Lesion-induced increase in survival and migration of human neural progenitor cells releasing GDNF. Cell Transplant (2008) 1.05

5-Bromo-2'-deoxyuridine is selectively toxic to neuronal precursors in vitro. Eur J Neurosci (2005) 1.03

Requirement for neurogenesis to proceed through the division of neuronal progenitors following differentiation of epidermal growth factor and fibroblast growth factor-2-responsive human neural stem cells. Stem Cells (2004) 1.03

Regionally specified human neural progenitor cells derived from the mesencephalon and forebrain undergo increased neurogenesis following overexpression of ASCL1. Stem Cells (2009) 1.02

Normal Neurogenesis but Abnormal Gene Expression in Human Fragile X Cortical Progenitor Cells. Stem Cells Dev (2008) 1.02

Control of neurogenesis and tyrosine hydroxylase expression in neural progenitor cells through bHLH proteins and Nurr1. Exp Neurol (2006) 1.02

Neurospheres modified to produce glial cell line-derived neurotrophic factor increase the survival of transplanted dopamine neurons. J Neurosci Res (2002) 1.01

Clinical translation of stem cells in neurodegenerative disorders. Cell Stem Cell (2012) 1.01

The amazing astrocyte. Nature (2002) 1.00

Modeling human retinal development with patient-specific induced pluripotent stem cells reveals multiple roles for visual system homeobox 2. Stem Cells (2014) 0.99

Stem cells as a potential treatment of neurological disorders. Curr Opin Pharmacol (2004) 0.98

A high concentration of epidermal growth factor increases the growth and survival of neurogenic radial glial cells within human neurosphere cultures. Stem Cells (2007) 0.96

Low concentrations of extracellular FGF-2 are sufficient but not essential for neurogenesis from human neural progenitor cells. Mol Cell Neurosci (2006) 0.95

Rotenone-induced caspase 9/3-independent and -dependent cell death in undifferentiated and differentiated human neural stem cells. J Neurochem (2005) 0.95

Stem cell biologists sure play a mean pinball. Nat Biotechnol (2010) 0.94

Regulation of prenatal human retinal neurosphere growth and cell fate potential by retinal pigment epithelium and Mash1. Stem Cells (2008) 0.93

Ex vivo delivery of GDNF maintains motor function and prevents neuronal loss in a transgenic mouse model of Huntington's disease. Exp Neurol (2010) 0.93

Stem cell transplantation for motor neuron disease: current approaches and future perspectives. Neurotherapeutics (2011) 0.92

BDNF-, IGF-1- and GDNF-secreting human neural progenitor cells rescue amyloid β-induced toxicity in cultured rat septal neurons. Neurochem Res (2011) 0.91

EGF and FGF-2 responsiveness of rat and mouse neural precursors derived from the embryonic CNS. Brain Res Bull (2005) 0.91

Ocular changes in TgF344-AD rat model of Alzheimer's disease. Invest Ophthalmol Vis Sci (2014) 0.91

Stimulation of GABA-induced Ca2+ influx enhances maturation of human induced pluripotent stem cell-derived neurons. PLoS One (2013) 0.90

Isolating, expanding, and infecting human and rodent fetal neural progenitor cells. Curr Protoc Stem Cell Biol (2008) 0.90

A critical period in cortical interneuron neurogenesis in down syndrome revealed by human neural progenitor cells. Dev Neurosci (2009) 0.89

Back to the future: how human induced pluripotent stem cells will transform regenerative medicine. Hum Mol Genet (2013) 0.89

Differentiation and migration of long term expanded human neural progenitors in a partial lesion model of Parkinson's disease. Int J Biochem Cell Biol (2004) 0.88

Molecular differences caused by differentiation of 3T3-L1 preadipocytes in the presence of either dehydroepiandrosterone (DHEA) or 7-oxo-DHEA. Biochemistry (2002) 0.88

Stem cell model of spinal muscular atrophy. Arch Neurol (2010) 0.86

Glial cell line-derived neurotrophic factor-secreting human neural progenitors show long-term survival, maturation into astrocytes, and no tumor formation following transplantation into the spinal cord of immunocompromised rats. Neuroreport (2014) 0.85

Massively parallel signature sequencing profiling of fetal human neural precursor cells. Stem Cells Dev (2006) 0.85

A simple alkaline method for decellularizing human amniotic membrane for cell culture. PLoS One (2013) 0.84

Stem cells for neurodegenerative disorders: where can we go from here? BioDrugs (2002) 0.84

Acute glial activation by stab injuries does not lead to overt damage or motor neuron degeneration in the G93A mutant SOD1 rat model of amyotrophic lateral sclerosis. Exp Neurol (2009) 0.84

Ergosteroids. VI. Metabolism of dehydroepiandrosterone by rat liver in vitro: a liquid chromatographic-mass spectrometric study. J Chromatogr B Analyt Technol Biomed Life Sci (2002) 0.84

Patient-derived skeletal dysplasia induced pluripotent stem cells display abnormal chondrogenic marker expression and regulation by BMP2 and TGFβ1. Stem Cells Dev (2014) 0.83

Heparin stabilizes FGF-2 and modulates striatal precursor cell behavior in response to EGF. Exp Neurol (2004) 0.83

Human retinal progenitor cells grown as neurospheres demonstrate time-dependent changes in neuronal and glial cell fate potential. Ann N Y Acad Sci (2005) 0.82

Transplantation of human glial-restricted neural precursors into injured spinal cord promotes functional and sensory recovery without causing allodynia. Cytotherapy (2010) 0.82

Rapid genetic targeting of pial surface neural progenitors and immature neurons by neonatal electroporation. Neural Dev (2012) 0.82

Gonadectomy and dehydroepiandrosterone (DHEA) do not modulate disease progression in the G93A mutant SOD1 rat model of amyotrophic lateral sclerosis. Amyotroph Lateral Scler (2012) 0.81

Stem cells in the injured spinal cord: reducing the pain and increasing the gain. Nat Neurosci (2005) 0.80

Musashi1 antigen expression in human fetal germinal matrix development. Exp Neurol (2006) 0.80

From embryonic stem cells to mature photoreceptors. Nat Biotechnol (2013) 0.79

A new tool in the battle against Alzheimer's disease and aging: ex vivo gene therapy. Rejuvenation Res (2005) 0.79

Redox reactions of dehydroepiandrosterone and its metabolites in differentiating 3T3-L1 adipocytes: A liquid chromatographic-mass spectrometric study. Arch Biochem Biophys (2006) 0.79

Gene expression changes in the MAPK pathway in both Fragile X and Down syndrome human neural progenitor cells. Am J Stem Cells (2012) 0.79

Combining growth factors, stem cells, and gene therapy for the aging brain. Ann N Y Acad Sci (2004) 0.79

The in vitro survival of human monosomies and trisomies as embryonic stem cells. Stem Cell Res (2012) 0.79

In Vivo Tracking of Human Neural Progenitor Cells in the Rat Brain Using Magnetic Resonance Imaging Is Not Enhanced by Ferritin Expression. Cell Transplant (2015) 0.79

C(19)-5-ene steroids in nature. Vitam Horm (2005) 0.79

Transformations of DHEA and its metabolites by rat liver. Lipids (2002) 0.79

Stem cells for cell replacement therapy: a therapeutic strategy for HD? Mov Disord (2014) 0.78

Real time imaging of human progenitor neurogenesis. PLoS One (2010) 0.77

Identification of steroid derivatives that function as potent antiandrogens. Int J Cancer (2005) 0.77